FIELD: biotechnology.
SUBSTANCE: group of inventions relates to biotechnology and can be used in medicine. Group of inventions discloses a nucleic acid molecule containing a PRDM16 gene sequence, an expression vector containing said nucleic acid, a method for delivery thereof and a method for reducing body weight in a mammal.
EFFECT: nucleic acid, according to the present invention, can be used for effective reduction of body weight in mammals, in particular, due to reduction of fat deposits.
9 cl, 3 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NUCLEIC ACID DESIGNED TO REDUCE MAMMALIAN BODY WEIGHT, EXPRESSION VECTOR FOR EXPRESSION IN MAMMALIAN CELLS, METHOD FOR ITS DELIVERY AND METHOD FOR REDUCING MAMMALIAN BODY WEIGHT | 2023 |
|
RU2810191C1 |
| NUCLEIC ACID FOR ALLOTOPIC EXPRESSION OF MT-ND4 GENE | 2023 |
|
RU2809065C1 |
| MITOCHONDRIAL LOCALIZATION PEPTIDE, NUCLEIC ACID FOR ALLOTOPIC EXPRESSION OF MT-ND4 GENE CONTAINING ITS EXPRESSION VECTOR AND ITS USE | 2023 |
|
RU2817420C1 |
| VIRAL EXPRESSION CONSTRUCT COMPRISING FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE | 2018 |
|
RU2839576C2 |
| USING VECTOR FOR REDUCING IMMUNE RESPONSE IN VIRAL DELIVERY OF AIPL1 | 2023 |
|
RU2818342C1 |
| MINI-PROTEIN USH2A, NUCLEIC ACID CODING MINI-PROTEIN USH2A, AND EXPRESSION VECTOR FOR GENE THERAPY CONTAINING SAME | 2023 |
|
RU2822884C1 |
| EXPRESSION ADENO-ASSOCIATED VECTOR FOR TREATING MULTIPLE EPIPHYSEAL DYSPLASIA CAUSED BY MUTATIONS IN SLC26A2 GENE | 2024 |
|
RU2836489C1 |
| GENETIC CONSTRUCT AND METHOD FOR EXPRESSION OF ERVW-1 AND MYMK | 2025 |
|
RU2839754C1 |
| VECTORS AND SEQUENCES FOR TREATING DISEASES | 2011 |
|
RU2588667C2 |
| CODON-OPTIMISED HAIPL1-ENCODING NUCLEOTIDE SEQUENCE AND EXPRESSION VECTOR CONTAINING SAID SEQUENCE | 2021 |
|
RU2785621C1 |
